Prise en charge de la grossesse extra-utérine dans les pays en voie de développement : exemple d'une maternité de référence au Niger

Ultrasound Diagnosis of Polycystic Ovarian Syndrome: Current Guidelines, Criticism and Possible Update

“…The same was observed by most African authors MAJHI [2,6]. We agree with Nayama [7] that in our regions women only consult in the first trimester for signs that may reflect abnormal changes in pregnancy. This may explain the delays in diagnosis and management noted in our patients unlike what is encountered in developed countries [8] where the diagnosis is made early.…”

“…Six patients (12%) were in hemorrhagic shock and 30 patients (60%) were anemic and of these, 10 (33%) required transfusion. This high rate of patients with hemodynamic instability was also observed in other African series [6,7,10], due to the late diagnosis often at ruptured EP stage. The diagnosis of EP in 42 patients (84%) was established on admission based on clinical and / or ultrasound evidence.…”

“…Indeed, EP is a pathology of the young sexually active woman, and is associated with low parity [6,7].…”

“…The laparoscopic approach has the advantage of being minimally invasive, which is associated with an earlier discharge and a lower risk of postoperative adhesions compared to laparotomy [9]. We managed one case medically, similar to the Nayama study where only one case of medical treatment was performed [7]. Increased awareness by women of childbearing age associated with equipment in our laboratories would allow more patients with EP to receive medical treatment.…”

Grossesse Extra - Uterine Au Centre Hospitalier Nationale De Nouakchott : Aspects Epidemiologiques, Cliniques Et Therapeutiques

“…L'incidence de la GEU dans les pays développés est de l'ordre de 100 à 175 par an pour 100 000 femmes âgées de 15 à 44 ans [3]. Plusieurs études récentes ont révélé l'augmentation constante de la fréquence de la GEU, une augmentation liée à l'expansion des infections sexuellement transmissibles (IST) et du tabac qui sont associés au risque important de séquelles et sont un marqueur de santé publique justifiant un diagnostic précoce [5]. Ces dernières années, beaucoup de progrès ont été réalisés en vue d'améliorer la prise en charge et le pronostic de la GEU essentiellement dans les pays développés : apport de l'échographie pelvienne (endovaginale) et des dosages biologiques sanguins (bêta hCG plasmatique, progestérone).…”